Geode Capital Management LLC raised its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 4.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,505,652 shares of the business services provider's stock after purchasing an additional 69,099 shares during the quarter. Geode Capital Management LLC owned 2.97% of Exponent worth $173,597,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Inspire Advisors LLC grew its position in Exponent by 1.3% during the second quarter. Inspire Advisors LLC now owns 7,615 shares of the business services provider's stock valued at $724,000 after buying an additional 98 shares during the period. Caprock Group LLC grew its holdings in Exponent by 4.2% during the second quarter. Caprock Group LLC now owns 3,296 shares of the business services provider's stock valued at $314,000 after purchasing an additional 134 shares during the period. Raymond James Trust N.A. increased its position in Exponent by 2.8% in the second quarter. Raymond James Trust N.A. now owns 6,230 shares of the business services provider's stock worth $593,000 after buying an additional 172 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Exponent by 11.0% in the second quarter. Parkside Financial Bank & Trust now owns 2,008 shares of the business services provider's stock worth $191,000 after buying an additional 199 shares during the period. Finally, Mitchell & Pahl Private Wealth LLC lifted its position in shares of Exponent by 3.7% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 5,961 shares of the business services provider's stock valued at $687,000 after buying an additional 214 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company's stock.
Insider Activity at Exponent
In related news, Director Paul R. Johnston sold 14,000 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total value of $1,464,400.00. Following the transaction, the director now directly owns 80,742 shares of the company's stock, valued at approximately $8,445,613.20. The trade was a 14.78 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Carol Lindstrom sold 1,039 shares of the company's stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $96.32, for a total value of $100,076.48. Following the completion of the transaction, the director now owns 5,871 shares of the company's stock, valued at $565,494.72. The trade was a 15.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 30,339 shares of company stock worth $3,103,065. 2.10% of the stock is owned by corporate insiders.
Exponent Trading Down 0.1 %
Exponent stock traded down $0.10 during midday trading on Monday, hitting $93.06. The stock had a trading volume of 314,647 shares, compared to its average volume of 242,411. Exponent, Inc. has a 52-week low of $68.70 and a 52-week high of $115.75. The company has a market capitalization of $4.72 billion, a PE ratio of 45.00 and a beta of 0.70. The firm's fifty day moving average is $101.86 and its two-hundred day moving average is $102.38.
Exponent Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be given a dividend of $0.28 per share. The ex-dividend date is Friday, December 6th. This represents a $1.12 annualized dividend and a dividend yield of 1.20%. Exponent's payout ratio is 54.11%.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.